Gottfried von Keudell, MD PhD
3 clinical trials · Sponsor
◉ Watch Gottfried von Keudell, MD PhD
| Record | Firm | Date |
|---|---|---|
| Rituximab Plus Venetoclax in Front Line Marginal Zone Lymphoma (NCT06510309) | Gottfried von Keudell, MD PhD | 2026-02-11 |
| Odronextamab in Low Tumor Volume Advanced FL (NCT07128641) | Gottfried von Keudell, MD PhD | 2025-09-08 |
| Epcoritamab in Previously Treated WM (NCT06510491) | Gottfried von Keudell, MD PhD | 2024-12-06 |
Track Gottfried von Keudell, MD PhD automatically
Every clearance here is in the API, with alerts when new ones post.